Status of diabetes care among community pharmacy patients with diabetes: Analysis of the Medical Expenditure Panel Survey

Journal of the American Pharmacists Association

Volumn 50, Issue 4, 2010, Pages 478-484

  Wang, Junling ^a   Thomas, Jeremy ^b   Byrd, Debbie ^c   Nola, Kamala ^d   Liu, Jing ^e  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c UNIVERSITY OF TENNESSEE   (United States)

^d LIPSCOMB UNIVERSITY   (United States)

^e SHANDONG UNIVERSITY   (China)

Author keywords

Community pharmacy; Diabetes; Medication therapy management services; Practice standards; Surveys

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE MANAGEMENT; FEMALE; HEALTH CARE QUALITY; HEALTH CARE SURVEY; HEALTH SERVICE; HUMAN; MALE; MIDDLE AGED; PHARMACY; STATISTICS; UNITED STATES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; DIABETES COMPLICATIONS; DIABETES MELLITUS; DISEASE MANAGEMENT; FEMALE; HEALTH CARE SURVEYS; HUMANS; MALE; MIDDLE AGED; PHARMACIES; PROCESS ASSESSMENT (HEALTH CARE); UNITED STATES; VOLUNTARY HEALTH AGENCIES; YOUNG ADULT;

EID: 78149483110     PISSN: 15443191     EISSN: 15443450     Source Type: Journal    
DOI: 10.1331/JAPhA.2010.08173     Document Type: Article

References (28)

1. Cioffi ST, Caron MF, Kalus JS, et al. Glycosylated hemoglobin, cardiovascular, and renal outcomes in a pharmacist-managed clinic. Ann Pharmacother. 2004;38:771-5.
2. Centers for Disease Control and Prevention. Crude and age-adjusted prevalence of diagnosed diabetes per 100 population, United States, 1980-2005. Accessed at www.cdc.gov/diabetes/statistics/prev/national/figage.htm, November 18, 2008.
3. American Diabetes Association. Economic costs of diabetes in the U.S. in 2007. Diabetes Care. 2008;31:596-615.
4. American Diabetes Association. Economic consequences of diabetes mellitus in the U.S. in 1997. Diabetes Care. 1998;21:296-309.
5. Armor BL, Britton ML. Diabetes mellitus non-glucose monitoring: point-of-care testing. Ann Pharmacother. 2004;38:1039-47.
6. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2005;28(suppl 1):S4-36.
7. Saaddine JB, Engelgau MM, Beckles GL, et al. A diabetes report card for the United States: quality of care in the 1990s. Ann Intern Med. 2002;136:565-74.
8. Fera T, Bluml BM, Ellis WM, et al. The Diabetes Ten City Challenge: interim clinical and humanistic outcomes of a multisite community pharmacy diabetes care program. J Am Pharm Assoc. 2008;48:181-90.
9. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977-86.
10. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet. 1998;352:837-53.
11. Cranor CW, Christensen DB. The Asheville Project: short-term outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc. 2003;43:149-59.
12. Cranor CW, Bunting BA, Christensen DB. The Asheville Project: long-term clinical and economic outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc. 2003;43:173-84.
13. Brooks AD, Rihani RS, Derus CL. Pharmacist membership in a medical group's diabetes health management program. Am J Health Syst Pharm. 2007;64:617-21.
14. Martin OJ, Wu WC, Taveira TH, et al. Multidisciplinary group behavioral and pharmacologic intervention for cardiac risk reduction in diabetes: a pilot study. Diabetes Educ. 2007;33:118-27.
15. Scott DM, Boyd ST, Stephan M, et al. Outcomes of pharmacist-managed diabetes care services in a community health center. Am J Health Syst Pharm. 2006;63:2116-22.
16. Wubben DP, Vivian EM. Effects of pharmacist outpatient interventions on adults with diabetes mellitus: a systematic review. Pharmacotherapy. 2008;28:421-36.
17. Shane-McWhorter L, Fermo JD, Bultemier NC, Oderda GM. National survey of pharmacist certified diabetes educators. Pharmacotherapy. 2002;22:1579-93.
18. McClellan MB. Testimony of Mark B. McClellan, MD, PhD, Administrator, Centers for Medicare & Medicaid Services, before the House Committee on Energy and Commerce Subcommittee on Health Hearing on Implementation of the Medicare Prescription Drug Benefit. Accessed at www.cms.gov/hearingstestimony/ downloads/testimonyfinal3.1.06.pdf, May 22, 2010.
19. Agency for Healthcare Research and Quality. Medical Expenditure Panel Survey. Accessed at www.meps.ahrq.gov/mepsweb, March 15, 2008.
20. American Diabetes Association. Standards of medical care in diabetes-2008. Diabetes Care. 2008;31(suppl 1):S12-54.
21. Goldberg RB, Mellies MJ, Sacks FM, et al. Cardiovascular events and their reduction with pravastatin in diabetes and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analysis in the Cholesterol and Recurrent Events (CARE) trial. Circulation. 1998;98:2513-9.
22. Saaddine JB, Cadwell B, Gregg EW, et al. Improvements in diabetes progress of care and intermediate outcomes: United States, 1998-2002. Ann Intern Med. 2006;144:465-74.
23. Garrett DG, Bluml BM. Patient self-management program for diabetes: first-year clinical, humanistic, and economic outcomes. J Am Pharm Assoc. 2005;45:130-7.
24. Stagnitti MN. Statistical Brief #200: comparing population characteristics of persons purchasing prescribed drugs from mail order pharmacies with persons purchasing prescribed drugs from other outlets, 2005. Accessed at www.meps.ahrq.gov/mepsweb/data-files/publications/st200/stat200.pdf, November 18, 2008.
25. Kalsekar I, Sheehan C, Peak A. Utilization patterns and medication adherence in patients with type 2 diabetes: variation based on type of pharmacy (chain vs. independent). Res Social Adm Pharm. 2007;3:378-91.
26. Campbell RK. Role of the pharmacist in diabetes management. Am J Health Syst Pharm. 2002;59(suppl 9):S18-21.
27. Agency for Healthcare Research and Quality. National Healthcare Disparities Report, 2005. Accessed at www.ahrq.gov/qual/nhdr05/nhdr05.htm, November 18, 2008.
28. Agency for Healthcare Research and Quality. National Healthcare Quality Report, 2005. Accessed at www.ahrq.gov/qual/nhqr05/nhqr05.htm, November 18, 2008.